רשימת פרסומים עדכנית עדכניים של  ד"ר  נאדר טרביה  -Nader  Tarabeih

נאדר  טרביה 

PUBLICATIONS

1. Livshits, G., Tarabeih, N., Kalinkovich, A., Shalata, A., & Ashkenazi, S. (2025). Metabolic and Inflammatory Biomarkers Predicting Sarcopenic Obesity and Cardiometabolic Risk in Arab Women: A Cross-Sectional Study. International journal of molecular sciences, 26(12), 5699. https://doi.org/10.3390/ijms26125699 (IF=4.9, Q1)

 

2. Tarabeih, N., Kalinkovich, A., Ashkenazi, S., Shalata, A., & Livshits, G. (2024). Common Genetic Factors May Play a Role in the Relationships Between Body Composition, Adipokines, and Low-Back-Pain-Related Disability. Biomolecules, 14(11), 1426. https://doi.org/10.3390/biom14111426 (IF=4.8, Q1 in Biochemistry)

 

3. Tarabeih, N., Kalinkovich, A., Ashkenazi, S., Cherny, S. S., Shalata, A., & Livshits, G. (2024). Analysis of the Associations of Measurements of Body Composition and Inflammatory Factors with Cardiovascular Disease and Its Comorbidities in a Community-Based Study. Biomedicines, 12(5), 1066. https://doi.org/10.3390/biomedicines12051066 (IF=3.9, Q1 in Biochemistry, Genetics and Molecular Biology)

 

4. Tarabeih, N., Kalinkovich, A., Ashkenazi, S., Cherny, S. S., Shalata, A., & Livshits, G. (2024). Relationships between Circulating Biomarkers and Body Composition Parameters in Patients with Metabolic Syndrome: A Community-Based Study. International journal of molecular sciences, 25(2), 881. https://doi.org/10.3390/ijms25020881 (IF=4.9, Q1 in Biochemistry & Molecular Biology)

 

 

5. Tarabeih, N., Shalata, A., Kalinkovich, A., Higla, O., & Livshits, G. (2023). Elevated circulating levels of IL-34 are strongly associated with osteoporosis. Archives of osteoporosis, 18(1), 132. https://doi.org/10.1007/s11657-023-01343-6(IF=3.1, Q1 in Orthopedics)

6. Tarabeih, N., Kalinkovich, A., Shalata, A., Higla, O., & Livshits, G. (2023). Pro-Inflammatory Biomarkers Combined with Body Composition Display a Strong Association with Knee Osteoarthritis in a Community-Based Study. Biomolecules, 13(9), 1315. https://doi.org/10.3390/biom13091315 (IF=4.8, Q1 in Biochemistry)

 

7. Tarabeih, N., Shalata, A., Higla, O., Kalinkovich, A., & Livshits, G. (2022). The search for systemic biomarkers for monitoring degenerative lumbar spinal disorders. Osteoarthritis and cartilage open, 4(4), 100323. https://doi.org/10.1016/j.ocarto.2022.100323 (IF=2.4, Q2 in Biomedical Engineering)

 

8. Tarabeih, N., Masharawi, Y., Shalata, A., Higla, O., Kalinkovich, A., & Livshits, G. (2022). Scoliosis and skeletal muscle mass are strongly associated with low back pain-related disability in humans: An evolutionary anthropology point of view. American journal of human biology : the official journal of the Human Biology Council, 34(8), e23757. https://doi.org/10.1002/ajhb.23757 (IF=1.6, Q1 in Anthropology)

 

 

9. Tarabeih, N., Kalinkovich, A., Shalata, A., Cherny, S. S., & Livshits, G. (2022). Deciphering the Causal Relationships Between Low Back Pain Complications, Metabolic Factors, and Comorbidities. Journal of pain research, 15, 215–227.https://doi.org/10.2147/JPR.S349251 (IF=2.5, Q2 in Anesthesiology and Pain Medicine)

 

 

10. Tarabeih, N., Kalinkovich, A., Shalata, A., & Livshits, G. (2020). Circulating Levels of Visceral Adipose Tissue-Derived Serine Protease Inhibitor (Vaspin) Appear as a Marker of Musculoskeletal Pain Disability. Diagnostics (Basel, Switzerland), 10(10), 797.https://doi.org/10.3390/diagnostics10100797 (IF=3.0, Q2 in clinical biochemistry)

 

 

11. Tarabeih, N., Shalata, A., Trofimov, S., Kalinkovich, A., & Livshits, G. (2019). Growth and differentiation factor 15 is a biomarker for low back pain-associated disability. Cytokine, 117, 8–14. https://doi.org/10.1016/j.cyto.2019.01.011 (IF=3.7, Q2 in Biochemistry)

 

 

12. Shalata, A., Mahroom, M., Milewicz, D. M., Limin, G., Kassum, F., Badarna, K., Tarabeih, N., Assy, N., Fell, R., Cohen, H., Nashashibi, M., Livoff, A., Azab, M., Habib, G., Geiger, D., Weissbrod, O., & Nseir, W. (2018). Fatal thoracic aortic aneurysm and dissection in a large family with a novel MYLK gene mutation: delineation of the clinical phenotype. Orphanet journal of rare diseases, 13(1), 41. https://doi.org/10.1186/s13023-018-0769-7 (IF=3 .4, Q1 in Medicine)